Delivery Order SPE2DB20D9135-SPE2DB22FD2VM
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,612.88 firm fixed-price delivery order is for Xolair 150 mg/1.2 ml powder, a specialized medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which provides a comprehensive range of pharmaceutical items to fulfill the recurring...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,557.60 firm fixed-price delivery order is for the supply of Xolair 150 mg/ml syringes, a specialty medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $46,531.20 firm fixed-price delivery order is for the supply of Xolair 150 mg/1.2 ml powder vials, with an ultimate completion date of October 13, 2021. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $37,224.96 firm fixed-price delivery order for the supply of Xolair 150 mg/1.2 ml powder vials, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,189.60 firm fixed-price delivery order is for the supply of Xolair 150 mg/mL syringes, a specialty biologic medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $74,275.20 firm fixed-price delivery order contract is for the provision of Xolair 150 mg/1.2 ml powder vials, a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,247.70 firm fixed-price delivery order is for the supply of Xolair 150 mg/ml syringes, a specialized biologic medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,642.20, is for the delivery of Xolair 150 mg/1.2 ml powder vials to support the recurring medical supply needs of military healthcare facilities. This contract award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,584.16 firm fixed-price delivery order is for the supply of Xolair 150 mg/1.2 ml powder vials, which are used to treat certain respiratory conditions. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $74,275.20 firm fixed-price delivery order is for the supply of Xolair 150 mg/1.2 ml powder vials, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure...
- SPE2DB20D9135Indefinite Delivery Contract
- SPE2DB20D9135-SPE2DB22FD2VMDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,204.16 delivery order is for the supply of Xolair 150 mg/1.2 ml powder vials, a specialty pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to Department of Defense healthcare facilities, solidifying the company's role as a crucial supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 11/5/21 |